Can a single injection of ART105 safely alter key body markers?
Knowledge-focused
Not yet recruiting
This early-stage trial aims to see if a single injection of ART105 is safe and tolerable in healthy adults aged 18 to 55. It also looks at how the drug moves through the body and whether it changes urine PC1 levels. Participants receive one dose and are followed for about three m…
Phase: PHASE1 • Sponsor: Arnatar Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC